Besides stabilization and regression of atherosclerotic plaques, statins were shown to reduce inflammation [lowering of levels of CRP, fibrinogen, neutrophils], which, in patients with PAD correlates with improved survival [50,51]. This evidence concerns the gene CRP and peripheral arterial disease.